These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11190567)

  • 1. [File no. 41. VHL (von Hippel-Lindau). Tumor suppressor gene].
    Soussi T
    Bull Cancer; 2000 Nov; 87(11):771-2. PubMed ID: 11190567
    [No Abstract]   [Full Text] [Related]  

  • 2. [Von Hippel-Lindau disease].
    Shuin T; Ashida S; Yao M; Kanno H
    Nihon Rinsho; 2000 Jul; 58(7):1448-54. PubMed ID: 10921322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A.
    Chen F; Slife L; Kishida T; Mulvihill J; Tisherman SE; Zbar B
    J Med Genet; 1996 Aug; 33(8):716-7. PubMed ID: 8863170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
    Stolle C; Glenn G; Zbar B; Humphrey JS; Choyke P; Walther M; Pack S; Hurley K; Andrey C; Klausner R; Linehan WM
    Hum Mutat; 1998; 12(6):417-23. PubMed ID: 9829911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel mutation (c279delC) and a polymorphism (c291C>G) in the von Hippel-Lindau gene in Italian patients.
    Moore PS; Antonello D; Martignoni G; Racchini C; Ventrucci M; Scarpa A
    Hum Mutat; 2000 Jun; 15(6):582. PubMed ID: 10862095
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress in the study of von Hippel-Lindau syndrome].
    Chen F; Wu M
    Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):236-8. PubMed ID: 9596966
    [No Abstract]   [Full Text] [Related]  

  • 7. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The von Hippel-Lindau tumor suppressor gene.
    Kondo K; Kaelin WG
    Exp Cell Res; 2001 Mar; 264(1):117-25. PubMed ID: 11237528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The von Hippel-Lindau tumour suppressor protein: new perspectives.
    Ohh M; Kaelin WG
    Mol Med Today; 1999 Jun; 5(6):257-63. PubMed ID: 10366821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PCR generated BsaJ I RFLP in the promoter of the von Hippel-Lindau disease (VHL) tumour suppressor gene.
    Geil L; Semenova E; Lerman MI; Kuzmin I
    Mol Cell Probes; 1998 Oct; 12(5):343-4. PubMed ID: 9778462
    [No Abstract]   [Full Text] [Related]  

  • 11. Von Hippel-Lindau (VHL) gene analysis in Italian families with VHL disease.
    Montera M; Bellone E; Ajmar F; Mandich P
    Contrib Nephrol; 1997; 122():109-11. PubMed ID: 9399050
    [No Abstract]   [Full Text] [Related]  

  • 12. Von Hippel-Lindau syndrome: hereditary cancer arising from inherited mutations of the VHL tumor suppressor gene.
    Humphrey JS; Klausner RD; Linehan WM
    Cancer Treat Res; 1996; 88():13-39. PubMed ID: 9239471
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer. Many vessels, faulty gene.
    Kaelin WG
    Nature; 1999 May; 399(6733):203-4. PubMed ID: 10353237
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene symbol: VHL. Disease: Von-Hippel-Lindau syndrome.
    Baker DW; Cherches IM; Rothberg PG
    Hum Genet; 2000 Jun; 106(6):671. PubMed ID: 10942119
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells.
    Gorospe M; Egan JM; Zbar B; Lerman M; Geil L; Kuzmin I; Holbrook NJ
    Mol Cell Biol; 1999 Feb; 19(2):1289-300. PubMed ID: 9891063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mosaicism in von Hippel-Lindau Disease.
    Murgia A; Martella M; Vinanzi C; Polli R; Perilongo G; Opocher G
    Hum Mutat; 2000 Jan; 15(1):114. PubMed ID: 10612832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable penetrance of familial pheochromocytoma associated with the von Hipple Lindau gene mutation, S68W. Mutations in brief no. 150. Online.
    Martin R; Hockey A; Walpole I; Goldblatt J
    Hum Mutat; 1998; 12(1):71. PubMed ID: 10627136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
    Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
    Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [VHL, angiogenesis and renal carcinoma: the puzzle is complete].
    Richard S
    Ann Pathol; 2000 Mar; 20(2):107-9. PubMed ID: 10740003
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.
    Gnarra JR; Duan DR; Weng Y; Humphrey JS; Chen DY; Lee S; Pause A; Dudley CF; Latif F; Kuzmin I; Schmidt L; Duh FM; Stackhouse T; Chen F; Kishida T; Wei MH; Lerman MI; Zbar B; Klausner RD; Linehan WM
    Biochim Biophys Acta; 1996 Mar; 1242(3):201-10. PubMed ID: 8603073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.